Rodman & Renshaw, LLC, a wholly owned subsidiary of Rodman & Renshaw Capital Group, Inc. (NASDAQ: RODM), announced that it acted as the exclusive placement agent to BioSante Pharmaceuticals Inc. (NASDAQ: BPAX) on the Company's $18.0 million registered direct offering.